1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
(
- Contribution to journal › Article
- 2019
-
Mark
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes : A nested, case–control study
(
- Contribution to journal › Article
- 2018
-
Mark
Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes : The SUMMIT VIP Study
(
- Contribution to journal › Article
- 2016
-
Mark
Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes
(
- Contribution to journal › Article
- 2015
-
Mark
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
(
- Contribution to journal › Article
-
Mark
Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study
(
- Contribution to journal › Article
- 2013
-
Mark
Comparison of grey scale median (GSM) measurement in ultrasound images of human carotid plaques using two different softwares.
(
- Contribution to journal › Article
- 2012
-
Mark
Soluble Urokinase Plasminogen Activator Receptor is Associated With Inflammation in the Vulnerable Human Atherosclerotic Plaque.
(
- Contribution to journal › Article